The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

Recruiting now · Phase 4

Conditions studied: Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection

In brief

Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.

Key facts

Study ID
NCT06236022
Run by
Tongji Hospital
People needed
276
Starts
2024-01-01
Expected to finish
2028-12-31
Last updated by the study team
2024-02-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.